BMY
★★☆☆☆ PasstemplateBristol-Myers Squibb Company
Healthcare · sector percentile 89
Session move
$59.59
Vol 0.78× avg
63/100 quant · tgt $66.13
RS60 -3.6% vs SPY · ADV$ 791.7M
session 2026-10-06 · Snapshot — not live tape
Since last scan
2026-10-06 → 2026-10-07
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-10-06 · scan 2026-10-07 · pushed 10-07 13:32 ET · Regular session (stale)
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $59.59
- Previous close
- $58.81
- Pushed last
- $59.70 (stale) · 10-07 13:32 ET · Regular session
- Session open
- $58.94
- Last session range
- $58.65 – $59.60
- 52-week range
- $41.13 – $68.64
- Session volume
- 9,884,873
- Avg volume (20d)
- 12,728,394
- Market cap
- $121.73B
- PE (TTM)
- 13.13
- Forward PE
- 9.05
- Dividend yield
- 4.27%
- 1y target est.
- $66.13
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.
If you put $1,000.00 in
1y ago
$1,379.39
+38%
5y ago
$1,266.89
+27%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
Bristol Myers' Sotyktu delivers durable PsA responses for two years, supporting its growth strategy as competition intensifies.
Yahoo · 2026-09-18
- Merck Stock Nearly Doubled Without A Change In Its Revenue Growth
Merck (MRK) stock returned about 87% over the past twelve months, climbing from roughly $79 to about $147. Nothing in the year's results looks like that. The medicines Merck sells today grew at their usual pace. Investors spent the year repricing what comes next.
Yahoo · 2026-09-18
- Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors
Bristol Myers Squibb (BMY) reached $63.75 at the closing of the latest trading day, reflecting a -1.02% change compared to its last close.
Yahoo · 2026-09-10
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — BMY scores 63.27/100 (Pass) with revenue growth at 5.7% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for BMY include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-29; cached Form 4 cluster (count, n=6, latest 2026-10-05); disclosure reasons form4_cluster_ambiguous.
- Target Upside — Consensus implied upside is 11.0%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-07$59.59+$0.7863.3Pass
- 2026-10-06$58.81−$2.3462.9Pass
- 2026-10-05$61.15−$0.3164.4Pass
- 2026-10-02$61.46−$0.9462.9Pass
- 2026-10-01$62.40−$0.4664.8Pass
- 2026-09-30$62.86−$1.0263.9Pass
- 2026-09-29$63.88+$1.0263.4Pass
- 2026-09-28$62.86+$1.3664.0Pass
- 2026-09-25$61.50+$0.3565.8Pass
- 2026-09-24$61.15−$1.1065.3Pass
- 2026-09-23$62.25−$0.3766.5Pass
- 2026-09-22$62.62−$0.4466.3Pass
- 2026-09-21$63.06+$0.2266.9Pass
- 2026-09-18$62.84−$0.7665.8Pass
- 2026-09-17$63.60−$0.1365.3Pass
- 2026-09-16$63.73−$0.3765.0Pass
- 2026-09-15$64.10+$0.4664.3Pass
- 2026-09-14$63.64−$0.1164.5Pass
- 2026-09-11$63.75−$0.6665.5Pass
- 2026-09-10$64.41−$0.2864.8Pass
- 2026-09-09$64.69−$2.1365.6Pass
- 2026-09-08$66.82$0.0065.0Pass
- 2026-09-07$66.82−$1.2765.0Pass
- 2026-09-04$68.09+$0.4365.8Pass
- 2026-09-03$67.66+$0.7465.8Pass
- 2026-09-02$66.92+$0.1165.8Pass
- 2026-09-01$66.81+$0.2365.8Pass
- 2026-08-31$66.58−$0.3764.9Pass
- 2026-08-28$66.95−$0.6265.3Pass
- 2026-08-27$67.57—65.3Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 31.2%
- vs 20d (z)
- -1.58
- Short vol
- 1,152,545
- Status
- ok
Squeeze pressure score
full21/100
- Short leg
- 4
- Call leg
- 54
- Activity
- 1.4
- Call vol share
- 47.7%
- PCR (vol)
- 1.09
- Call OI share
- 55.6%
- ATM IV
- 31.5%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
Disclosure score
0
- News
- 0
- Insider
- 0
- Earnings
- 0
Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.
Attention (~)
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +1.5%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- —
- SEC ↗42026-10-05
FORM 4
- SEC ↗42026-10-02
FORM 4
- SEC ↗42026-10-02
FORM 4
- SEC ↗42026-10-02
FORM 4
- SEC ↗42026-10-02
FORM 4
- SEC ↗42026-10-02
FORM 4
- SEC ↗42026-09-10
FORM 4
- SEC ↗42026-09-03
FORM 4
- SEC ↗42026-08-26
FORM 4
- SEC ↗42026-08-04
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.